XCures secured $46 million in Series B funding to expand its AI-powered medical record cleanup platform. The round, led by Innovius Capital, values the company at $127 million post-money and brings total funding to $76 million since its 2018 founding.

Originally a Cancer Commons spinout focused on cancer patient support, XCures pivoted to tackle healthcare's data chaos. The company processes 300 million medical records from over 550,000 healthcare locations, using AI to transform messy patient data into clinical intelligence that organizations can act on immediately.

CEO Mika Newton built the platform after discovering patient records arrived via fax and FedEx. Today, XCures combines proprietary machine learning with commercial AI tools through a custom governance framework. Annual recurring revenue grew from $3 million to $10 million in 2025, with projections exceeding $20 million in 2026.

Major clients include Exact Sciences and Novocure, using the tool for surgical scheduling and risk stratification. With $8.5 billion flowing to AI health tech year-to-date, XCures addresses the $350 billion administrative burden dragging down U.S. healthcare efficiency.